1. 2651 Comprehensive genomic profiling (CGP) identifies unique and abundant clinically relevant genomic alterations in rare histologies of renal cell carcinoma. (September 2015) Authors: Ali, S.; Choueiri, T.; Wang, K.; Khaira, D.; Johnson, A.; Squillace, R.; Elvin, J.; Chmielecki, J.; Yelensky, R.; Lipson, D.; Miller, V.; Ross, J.; Stein, M.; Pal, S.; Stephens, P. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S530 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2905 Genomic characterization of brain metastases and paired primary tumors reveals branched evolution and potential therapeutic targets. (September 2015) Authors: Brastianos, P.; Carter, S.; Santagata, S.; Cahill, D.; Taylor-Weiner, A.; Jones, R.; Ligon, K.; Tabernero, J.; Seoane, J.; Martinez Saez, E.; Johnson, B.; Choueiri, T.; Stemmer-Rachamimov, A.; Lin, N.; Beroukhim, R.; Batchelor, T.; Baselga, J.; Louis, D.; Hahn, W.; Getz, G. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S586 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 4LBA Cabozantinib versus everolimus in patients with advanced renal cell carcinoma: Results of the randomized phase 3 METEOR trial. (September 2015) Authors: Choueiri, T.; Escudier, B.; Powles, T.; Mainwaring, P.; Rini, B.; Donskov, F.; Hammers, H.; Hutson, T.; Roth, B.; Peltola, K.; Lee, J.L.; Heng, D.; Schmidinger, M.; Borgman-Hagey, A.; Hessel, C.; Scheffold, C.; Schwab, G.; Tannir, N.; Motzer, R. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S708 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Exercise, free radicals and oxidative stress. (April 2002) Authors: Cooper, C. E.; Vollaard, N. B. J.; Choueiri, T.; Wilson, M. T. Journal: Biochemical Society transactions Issue: Volume 30:Number 2(2002) Page Start: 280 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Pembrolizumab vs investigator-choice chemotherapy for previously treated advanced urothelial cancer: Phase 3 KEYNOTE-045 study. (February 2017) Authors: Necchi, A.; Bellmunt, J.; De Wit, R.; Vaughn, D.; Fradet, Y.; Lee, J.L.; Fong, L.; Vogelzang, N.; Climent, M.; Petrylak, D.; Choueiri, T.; Gerritsen, W.; Gurney, H.; Quinn, D.; Culine, S.; Sternberg, C.; Mai, Y.; Puhlmann, M.; Perini, R.; Bajorin, D. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗